May 11 2022
First quarter 2022 revenue increased 52% over prior year period BRANFORD, Conn., May 11, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today reported financial results for the quarter ended March 31, 2022. Recent Highlights Revenue of $4.9 million for
Feb 11 2022
BRANFORD, Conn., Feb. 11, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today announced the company will be participating in the following investor conferences. 11 th Annual SVB Leerink Global Healthcare Conference, Virtual Fireside Chat on Wednesday,